EUVIMEDEUVIMED entdecken
Crossref

Efbemalenograstim alfa, a long-acting granulocyte colony-stimulating factor, a novel dimeric G-CSF Fc fusion protein for reducing the risk of febrile neutropenia following chemotherapy

Simon Xi-Ming Li, Qing-Song Hou, Shu-Fang Wang, Jian-Min Chen, Wei Yao, Yan-Yan Fu, Li- Chuan Liu, Ren-Shu Li, Xiao Qiang Yan

Journal of Clinical and Experimental Hematology · 2023

DOI: 10.46439/hematol.2.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematology, 2023. Verfasst von Simon Xi-Ming Li und 8 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, S. X., Hou, Q., Wang, S., Chen, J., Yao, W., Fu, Y., Liu, L. C., Li, R., & Yan, X. Q. (2023). Efbemalenograstim alfa, a long-acting granulocyte colony-stimulating factor, a novel dimeric G-CSF Fc fusion protein for reducing the risk of febrile neutropenia following chemotherapy. Journal of Clinical and Experimental Hematology. https://doi.org/10.46439/hematol.2.009

Vancouver

Li SX, Hou Q, Wang S, Chen J, Yao W, Fu Y, et al. Efbemalenograstim alfa, a long-acting granulocyte colony-stimulating factor, a novel dimeric G-CSF Fc fusion protein for reducing the risk of febrile neutropenia following chemotherapy. Journal of Clinical and Experimental Hematology. 2023. doi:10.46439/hematol.2.009

BibTeX
@article{Li2023,
  author = {Li, Simon Xi-Ming and Hou, Qing-Song and Wang, Shu-Fang and Chen, Jian-Min and Yao, Wei and Fu, Yan-Yan and Liu, Li- Chuan and Li, Ren-Shu and Yan, Xiao Qiang},
  title = {Efbemalenograstim alfa, a long-acting granulocyte colony-stimulating factor, a novel dimeric G-CSF Fc fusion protein for reducing the risk of febrile neutropenia following chemotherapy},
  journal = {Journal of Clinical and Experimental Hematology},
  year = {2023},
  doi = {10.46439/hematol.2.009}
}
Kostenlos starten →